pSvida to list on Nasdaq
Tuesday, 10 June, 2008
WA-based biotech pSvida (ASX: PSD) is to reincorporate onto the Nasdaq, the American stock exchange.
The re-incorporation plan was first mooted in April. At a shareholders' meeting today, 94 per cent of shareholders, 192 in total, voted for the resolution, while six voted against it.
Between them the 192 shareholders hold around 96 per cent of the voting power.
The shareholders also voted to adopt a new employee incentive plan.
Proposed Australian trial eyes up blood testing for Alzheimer's
Utilising networks of GPs across three states, a large-scale study intends on combining digital...
Applications open for $300K pandemic therapeutics fellowships
Applications are now open for the Cumming Global Centre for Pandemic Therapeutics' inaugural...
CTA granted for CAR-T cell therapy for multiple myeloma
The Therapeutic Goods Administration has granted Clinical Trial Approval for KMCAR T-cell...
